A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan
Journal of Pharmacoepidemiology and Risk Management · 31.03.2026 · 18 (1) · 1-6
DOI: 10.56142/perm.26.0003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, erschienen am 31.03.2026. Verfasst von Sujeong Hwang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hwang, S., Jang, Y. M., Han, C., Song, H. J., & Shin, J. (2026). A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan. Journal of Pharmacoepidemiology and Risk Management, 18(1), 1-6. https://doi.org/10.56142/perm.26.0003
Vancouver
Hwang S, Jang YM, Han C, Song HJ, Shin J. A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan. Journal of Pharmacoepidemiology and Risk Management. 2026;18(1):1-6. doi:10.56142/perm.26.0003
BibTeX
@article{Hwang2026,
author = {Hwang, Sujeong and Jang, Yoon Min and Han, Changyoub and Song, Hong Ji and Shin, Ju-Young},
title = {A Comparative Analysis of Regulatory Approval and Safety Information for Major Anti-Obesity Medications in South Korea, the United States, Europe, and Japan},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2026},
volume = {18},
number = {1},
pages = {1--6},
doi = {10.56142/perm.26.0003}
}
EUVIMED